PL3766884T3 - Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania - Google Patents

Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania

Info

Publication number
PL3766884T3
PL3766884T3 PL19793622.2T PL19793622T PL3766884T3 PL 3766884 T3 PL3766884 T3 PL 3766884T3 PL 19793622 T PL19793622 T PL 19793622T PL 3766884 T3 PL3766884 T3 PL 3766884T3
Authority
PL
Poland
Prior art keywords
preparation
crystal form
method therefor
salt type
triazolopyrimidine compound
Prior art date
Application number
PL19793622.2T
Other languages
English (en)
Inventor
Kevin X Chen
Yanxin YU
Xinde CHEN
Li Zhang
Zhaoguo CHEN
Cheng Xie
Original Assignee
Medshine Discovery Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medshine Discovery Inc. filed Critical Medshine Discovery Inc.
Publication of PL3766884T3 publication Critical patent/PL3766884T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL19793622.2T 2018-04-28 2019-04-28 Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania PL3766884T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810399876 2018-04-28
PCT/CN2019/084822 WO2019206336A1 (zh) 2018-04-28 2019-04-28 一种三唑并嘧啶类化合物的晶型、盐型及其制备方法

Publications (1)

Publication Number Publication Date
PL3766884T3 true PL3766884T3 (pl) 2022-07-18

Family

ID=68294924

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19793622.2T PL3766884T3 (pl) 2018-04-28 2019-04-28 Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania

Country Status (9)

Country Link
US (1) US11649239B2 (pl)
EP (1) EP3766884B1 (pl)
JP (1) JP7406691B2 (pl)
CN (1) CN112105617B (pl)
DK (1) DK3766884T3 (pl)
ES (1) ES2908424T3 (pl)
PL (1) PL3766884T3 (pl)
PT (1) PT3766884T (pl)
WO (1) WO2019206336A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3766884T3 (pl) * 2018-04-28 2022-07-18 Medshine Discovery Inc. Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania
AR116315A1 (es) * 2018-09-12 2021-04-21 Dizal Jiangsu Pharmaceutical Co Ltd Compuestos de triazolo-pirimidina y usos de los mismos
US20220040184A1 (en) * 2018-11-20 2022-02-10 Merck Sharp Dohme Corp. Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
CA3150766A1 (en) * 2019-08-26 2021-03-04 Incyte Corporation Triazolopyrimidines as a2a / a2b inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4195729B2 (ja) * 1997-03-24 2008-12-10 協和醗酵工業株式会社 ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体
AR038366A1 (es) * 2001-11-30 2005-01-12 Schering Corp Compuestos de 1,2,4-triazolo [1,5-c] pirimidinas sustituidas, antagonistas del receptor de adenosina a2a, composiciones farmaceuticas, el uso de dichos compuestos para la manufactura de un medicamento para el tratamiento de enfermedades del sistema nervioso central y un kit que comprende combinacion
US20060058320A1 (en) * 2002-09-24 2006-03-16 Kyowa Hakko Kogyo Co., Ltd. [1,2,4] Triazolo[1,5-c]pyrimidine derivatives
PT3611174T (pt) * 2017-04-07 2022-07-07 Medshine Discovery Inc Derivado de [1,2,4]triazolo[1,5-c]pirimidina como inibidor do recetor a2a
PL3766884T3 (pl) * 2018-04-28 2022-07-18 Medshine Discovery Inc. Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania

Also Published As

Publication number Publication date
EP3766884A1 (en) 2021-01-20
US20210094957A1 (en) 2021-04-01
EP3766884B1 (en) 2022-02-09
DK3766884T3 (da) 2022-03-28
CN112105617B (zh) 2022-04-05
PT3766884T (pt) 2022-03-31
ES2908424T3 (es) 2022-04-29
CN112105617A (zh) 2020-12-18
WO2019206336A1 (zh) 2019-10-31
EP3766884A4 (en) 2021-03-31
JP2021522335A (ja) 2021-08-30
JP7406691B2 (ja) 2023-12-28
US11649239B2 (en) 2023-05-16

Similar Documents

Publication Publication Date Title
IL288997A (en) Salt forms of Bampedoic acid and methods of using them
EP3287444A4 (en) New crystal form of lenvatinib methanesulfonate salt and preparation method thereof
PL3766884T3 (pl) Postać krystaliczna i rodzaj soli związku triazolopirymidynowego oraz sposób jej wytwarzania
EP3763713A4 (en) CRYSTAL FORM AND SALT FORM OF A PYRIDOIMIDAZOLE COMPOUND AND THE METHOD FOR MANUFACTURING IT
EP3909953C0 (en) CRYSTALLINE FORM OF DI-P-TOLUOYL-L-TARTRATE OF UPADACITINIB
EP3502100A4 (en) CRYSTAL FORMS OF OZANIMOD AND MANUFACTURING METHOD THEREFOR
EP3502103A4 (en) CRYSTALLINE FORM, TYPE OF SALT OF A SUBSTITUTED 2-HYDRO-PYRAZOLE DERIVATIVE AND PREPARATION METHOD THEREOF
EP3677575A4 (en) CRYSTALLINE FORM OF OZANIMODHYDROCHLORIDE AND PRODUCTION METHOD THEREFOR
EP3725786A4 (en) CRYSTAL SHAPE AND SALT SHAPE OF A TGF-BRI INHIBITOR AND METHOD OF MANUFACTURING IT
EP3805229C0 (en) SALT OF A CONDENSATED RING PYRIMIDINE COMPOUND, ITS CRYSTAL FORM AND METHOD FOR THE PRODUCTION THEREOF AND THEREOF USE
EP3369733A4 (en) Crystal form of 4h-pyrazolo[1,5- ]benzoimidazole compound, preparation method therefor and intermediate thereof
PT3511333T (pt) Forma cristalina e forma de sal do composto 7hpirrolo[ 2,3-d]pirimidina e método de preparação para o mesmo
EP3613746A4 (en) JOINT OF THE CRYSTALLINE FORM EOC315 MOD.I AND MANUFACTURING METHOD FOR IT
ZA202004055B (en) Salt of phenylpropionamide derivative and preparation method therefor
EP3837239A4 (en) PROCESS FOR THE PREPARATION OF SOLRIAMFETOL AND SALT THEREOF
IL263868A (en) Crystal structures of aminomethyl-converted tetracyclines and processes for their preparation
EP3744712A4 (en) CRYSTALLINE FORMS OF MESACONIN AND THE MANUFACTURING PROCESS FOR IT
EP3269710A4 (en) Nintedanib diethanesulfonate salt crystal and preparation method and use thereof
EP3741746A4 (en) CRYSTAL FORM OF OXOPICOLINAMIDE DERIVATIVE AND MANUFACTURING PROCESS FOR IT
ZA202007037B (en) Crystal form of c-met inhibitor and salt form thereof and preparation method therefor
EP3508478A4 (en) TETRAHYDROISOQUINOLEIN SALT DERIVATIVE AND CRYSTALLINE THEREOF, PREPARATION METHOD AND APPLICATION THEREOF
IL274274A (en) Salt form and crystal form of compound as FGFR4 inhibitor and method of their preparation
EP3988553A4 (en) CRYSTALLINE AND SALT FORM OF A QUINAZOLINE COMPOUND, AND METHOD FOR THE PREPARATION THEREOF
PL4061772T3 (pl) Sposób wytwarzania argyrodytu litowego
EP3444248A4 (en) CRYSTALLINE SHAPE OF BREXPIPRAZOLE AND PREPARATION METHOD THEREOF